The effect of oral care using Artificial saliva to control dry mouth in patients with COVID-19 under non-invasive mechanical ventilation: A quasi-experimental study

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220223054107N1

Enrollment

Registered

2022-02-25

Start date

2022-03-01

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 patients. COVID-19, virus identified

Interventions

Intervention 1: Control group: This group receives only routine care (Chlorhexidine mouthwash 0.2% and normal saline) . Intervention 2: Intervention group: In this group, in addition to routine care

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients admitted to the intensive care unit with COVID- 19 (having a CT scan or positive PCR test) under non-invasive mechanical ventilation age over 18 years Patients with similar mechanical ventilation settings

Exclusion criteria

Exclusion criteria: Patients taking drugs associated with decreased salivary function. Patients with obvious oral lesions, pest Pregnant patients

Design outcomes

Primary

Measure	Time frame
Dry mouth. Timepoint: Examination and evaluation of patients' mouths in 4 stages including (day zero: before the start of non-invasive mechanical ventilation, first day: one day after the use of non-invasive mechanical ventilation until the third day (3 days after the use of non-invasive mechanical ventilation) . Method of measurement: Beck Oral Assessment Scale (BOAS) Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSorour Khari

Shahid Beheshti University of Medical Sciences

sorourkhari71@gmail.com+98 21 8865 5366

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026